vs

Side-by-side financial comparison of Epsilon Energy Ltd. (EPSN) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.

ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $14.8M, roughly 1.2× Epsilon Energy Ltd.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -83.9%, a 80.9% gap on every dollar of revenue. On growth, Epsilon Energy Ltd. posted the faster year-over-year revenue change (65.7% vs -25.6%). Over the past eight quarters, Epsilon Energy Ltd.'s revenue compounded faster (36.2% CAGR vs -10.1%).

Epsilon Composite is a French company created in 1987 by Stephane LULL, its current CEO. The company was founded in January 1987. Its production site is located in Gaillan, France. Stéphane Lull is the CEO.

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

EPSN vs RMTI — Head-to-Head

Bigger by revenue
RMTI
RMTI
1.2× larger
RMTI
$18.3M
$14.8M
EPSN
Growing faster (revenue YoY)
EPSN
EPSN
+91.4% gap
EPSN
65.7%
-25.6%
RMTI
Higher net margin
RMTI
RMTI
80.9% more per $
RMTI
-3.0%
-83.9%
EPSN
Faster 2-yr revenue CAGR
EPSN
EPSN
Annualised
EPSN
36.2%
-10.1%
RMTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EPSN
EPSN
RMTI
RMTI
Revenue
$14.8M
$18.3M
Net Profit
$-12.4M
$-554.0K
Gross Margin
21.1%
Operating Margin
-129.0%
-2.2%
Net Margin
-83.9%
-3.0%
Revenue YoY
65.7%
-25.6%
Net Profit YoY
-1535.0%
26.7%
EPS (diluted)
$-0.55
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPSN
EPSN
RMTI
RMTI
Q4 25
$14.8M
$18.3M
Q3 25
$9.0M
$15.9M
Q2 25
$11.6M
$16.1M
Q1 25
$16.2M
$18.9M
Q4 24
$8.9M
$24.7M
Q3 24
$7.3M
$28.3M
Q2 24
$7.3M
$25.8M
Q1 24
$8.0M
$22.7M
Net Profit
EPSN
EPSN
RMTI
RMTI
Q4 25
$-12.4M
$-554.0K
Q3 25
$1.1M
$-1.8M
Q2 25
$1.6M
$-1.5M
Q1 25
$4.0M
$-1.5M
Q4 24
$-760.8K
$-756.0K
Q3 24
$366.0K
$1.7M
Q2 24
$815.7K
$343.0K
Q1 24
$1.5M
$-1.7M
Gross Margin
EPSN
EPSN
RMTI
RMTI
Q4 25
21.1%
Q3 25
14.3%
Q2 25
15.6%
Q1 25
16.1%
Q4 24
14.7%
Q3 24
22.0%
Q2 24
17.6%
Q1 24
13.5%
Operating Margin
EPSN
EPSN
RMTI
RMTI
Q4 25
-129.0%
-2.2%
Q3 25
6.7%
-9.9%
Q2 25
7.1%
-8.4%
Q1 25
44.3%
-7.2%
Q4 24
6.8%
-2.1%
Q3 24
3.3%
6.8%
Q2 24
16.0%
2.0%
Q1 24
17.6%
-5.8%
Net Margin
EPSN
EPSN
RMTI
RMTI
Q4 25
-83.9%
-3.0%
Q3 25
11.9%
-11.0%
Q2 25
13.3%
-9.3%
Q1 25
24.8%
-8.0%
Q4 24
-8.5%
-3.1%
Q3 24
5.0%
5.9%
Q2 24
11.2%
1.3%
Q1 24
18.9%
-7.6%
EPS (diluted)
EPSN
EPSN
RMTI
RMTI
Q4 25
$-0.55
$-0.01
Q3 25
$0.05
$-0.05
Q2 25
$0.07
$-0.05
Q1 25
$0.18
$-0.04
Q4 24
$-0.04
$-0.02
Q3 24
$0.02
$0.04
Q2 24
$0.04
$0.01
Q1 24
$0.07
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPSN
EPSN
RMTI
RMTI
Cash + ST InvestmentsLiquidity on hand
$9.0M
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$124.7M
$37.0M
Total Assets
$228.2M
$57.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPSN
EPSN
RMTI
RMTI
Q4 25
$9.0M
$10.7M
Q3 25
$12.8M
$13.6M
Q2 25
$9.9M
$12.5M
Q1 25
$6.9M
$11.4M
Q4 24
$6.5M
$15.7M
Q3 24
$8.3M
$12.3M
Q2 24
$8.6M
$11.9M
Q1 24
$2.3M
$6.6M
Stockholders' Equity
EPSN
EPSN
RMTI
RMTI
Q4 25
$124.7M
$37.0M
Q3 25
$100.2M
$37.0M
Q2 25
$100.2M
$30.4M
Q1 25
$99.7M
$31.5M
Q4 24
$96.7M
$32.6M
Q3 24
$98.4M
$29.1M
Q2 24
$99.6M
$23.5M
Q1 24
$99.9M
$20.6M
Total Assets
EPSN
EPSN
RMTI
RMTI
Q4 25
$228.2M
$57.1M
Q3 25
$126.3M
$57.5M
Q2 25
$123.6M
$52.6M
Q1 25
$125.5M
$54.0M
Q4 24
$120.5M
$59.2M
Q3 24
$121.8M
$57.1M
Q2 24
$121.1M
$53.0M
Q1 24
$125.1M
$50.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPSN
EPSN
RMTI
RMTI
Operating Cash FlowLast quarter
$-277.0K
$2.3M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPSN
EPSN
RMTI
RMTI
Q4 25
$-277.0K
$2.3M
Q3 25
$4.0M
$-1.3M
Q2 25
$8.3M
$1.8M
Q1 25
$8.6M
$-3.5M
Q4 24
$5.0M
$865.0K
Q3 24
$2.7M
$4.3M
Q2 24
$5.4M
$1.4M
Q1 24
$3.7M
$-2.4M
Free Cash Flow
EPSN
EPSN
RMTI
RMTI
Q4 25
$2.2M
Q3 25
$-1.5M
Q2 25
$1.7M
Q1 25
$-3.5M
Q4 24
$470.0K
Q3 24
$4.1M
Q2 24
$1.2M
Q1 24
$-2.5M
FCF Margin
EPSN
EPSN
RMTI
RMTI
Q4 25
12.0%
Q3 25
-9.6%
Q2 25
10.5%
Q1 25
-18.8%
Q4 24
1.9%
Q3 24
14.4%
Q2 24
4.5%
Q1 24
-11.1%
Capex Intensity
EPSN
EPSN
RMTI
RMTI
Q4 25
0.5%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.6%
Q3 24
0.7%
Q2 24
1.1%
Q1 24
0.6%
Cash Conversion
EPSN
EPSN
RMTI
RMTI
Q4 25
Q3 25
3.70×
Q2 25
5.38×
Q1 25
2.14×
Q4 24
Q3 24
7.50×
2.57×
Q2 24
6.60×
4.20×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPSN
EPSN

Gas Oil Ngls And Condensate$13.3M90%
Gas Gathering And Compression$1.5M10%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

Related Comparisons